Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

RUDLOFF

Showing results (531-540 of 558) with videos related to

Pageof 56
Sort By:
Annals of Surgical Oncology|December 13, 2012
A novel nomogram for peritoneal mesothelioma predicts survivalNicholas P Schaub, Meghna Alimchandani, Martha Quezado, et al.
Cancer Chemotherapy and Pharmacology|October 12, 2018
Pharmacokinetic evaluation of the PNC disassembler metarrestin in wild-type and Pdx1-Cre;LSL-Kras<sup>G12D/+</sup>;Tp53<sup>R172H/+</sup> (KPC) mice, a genetically engineered model of pancreatic cancerTomas Vilimas, Amy Q Wang, Samarjit Patnaik, et al.
Molecular Cancer Therapeutics|August 30, 2024
Fatty Acid Derivatization and Cyclization of the Immunomodulatory Peptide RP-182 Targeting CD206high Macrophages Improve Antitumor ActivitySitanshu S Singh, Raul Calvo, Anju Kumari, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 17, 2013
IL-32 promotes angiogenesisClaudia A Nold-Petry, Ina Rudloff, Yvonne Baumer, et al.
Molecular Cancer Therapeutics|August 11, 2021
T Cell-Mediated Antitumor Immunity Cooperatively Induced By TGFβR1 Antagonism and Gemcitabine Counteracts Reformation of the Stromal Barrier in Pancreatic CancerDandan Li, Nicholas Schaub, Theresa M Guerin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 18, 2017
The Changing Paradigm of Management of Liver Abscesses in Chronic Granulomatous DiseaseDavid M Straughan, Kaitlin C McLoughlin, John E Mullinax, et al.
Journal of Applied Crystallography|April 6, 2012
PDB_REDO: automated re-refinement of X-ray structure models in the PDBRobbie P Joosten, Jean Salzemann, Vincent Bloch, et al.
Cell Chemical Biology|October 26, 2021
Protein engineering of a stable and potent anti-inflammatory IL-37-Fc fusion with enhanced therapeutic potentialAlexander Bujotzek, Georg Tiefenthaler, Laurent Lariviere, et al.
Plos Genetics|March 26, 2011
A novel unstable duplication upstream of HAS2 predisposes to a breed-defining skin phenotype and a periodic fever syndrome in Chinese Shar-Pei dogsMia Olsson, Jennifer R S Meadows, Katarina Truvé, et al.
Nature Immunology|March 3, 2015
IL-37 requires the receptors IL-18Rα and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transductionClaudia A Nold-Petry, Camden Y Lo, Ina Rudloff, et al.
Pageof 56

Showing results (531-540 of 558) with videos related to

Sort By:
Pageof 56
Annals of Surgical Oncology|December 13, 2012
A novel nomogram for peritoneal mesothelioma predicts survivalNicholas P Schaub, Meghna Alimchandani, Martha Quezado, et al.
Cancer Chemotherapy and Pharmacology|October 12, 2018
Pharmacokinetic evaluation of the PNC disassembler metarrestin in wild-type and Pdx1-Cre;LSL-Kras<sup>G12D/+</sup>;Tp53<sup>R172H/+</sup> (KPC) mice, a genetically engineered model of pancreatic cancerTomas Vilimas, Amy Q Wang, Samarjit Patnaik, et al.
Molecular Cancer Therapeutics|August 30, 2024
Fatty Acid Derivatization and Cyclization of the Immunomodulatory Peptide RP-182 Targeting CD206high Macrophages Improve Antitumor ActivitySitanshu S Singh, Raul Calvo, Anju Kumari, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 17, 2013
IL-32 promotes angiogenesisClaudia A Nold-Petry, Ina Rudloff, Yvonne Baumer, et al.
Molecular Cancer Therapeutics|August 11, 2021
T Cell-Mediated Antitumor Immunity Cooperatively Induced By TGFβR1 Antagonism and Gemcitabine Counteracts Reformation of the Stromal Barrier in Pancreatic CancerDandan Li, Nicholas Schaub, Theresa M Guerin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 18, 2017
The Changing Paradigm of Management of Liver Abscesses in Chronic Granulomatous DiseaseDavid M Straughan, Kaitlin C McLoughlin, John E Mullinax, et al.
Journal of Applied Crystallography|April 6, 2012
PDB_REDO: automated re-refinement of X-ray structure models in the PDBRobbie P Joosten, Jean Salzemann, Vincent Bloch, et al.
Cell Chemical Biology|October 26, 2021
Protein engineering of a stable and potent anti-inflammatory IL-37-Fc fusion with enhanced therapeutic potentialAlexander Bujotzek, Georg Tiefenthaler, Laurent Lariviere, et al.
Plos Genetics|March 26, 2011
A novel unstable duplication upstream of HAS2 predisposes to a breed-defining skin phenotype and a periodic fever syndrome in Chinese Shar-Pei dogsMia Olsson, Jennifer R S Meadows, Katarina Truvé, et al.
Nature Immunology|March 3, 2015
IL-37 requires the receptors IL-18Rα and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transductionClaudia A Nold-Petry, Camden Y Lo, Ina Rudloff, et al.
Pageof 56